Market Cap 83.51M
Revenue (ttm) 0.00
Net Income (ttm) -52.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.14
Volume 402,100
Avg Vol 336,412
Day's Range N/A - N/A
Shares Out 60.08M
Stochastic %K 45%
Beta -0.01
Analysts Strong Sell
Price Target $10.80

Latest News on ABOS

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

Oct 15, 2024, 8:00 AM EDT - 4 months ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

LENZ


Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024

Sep 25, 2024, 4:00 PM EDT - 5 months ago

Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024


Navigating Acumen's Alzheimer's Risk And Reward

Oct 3, 2023, 11:03 AM EDT - 1 year ago

Navigating Acumen's Alzheimer's Risk And Reward